3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Multiple Myeloma
166
Precursor Cell Lymphoblastic Leukemia-Lymphoma
47
Lymphoma
23
Neoplasms, Plasma Cell
21
Leukemia
21
Recurrence
20
Burkitt Lymphoma
18
Lymphoma, Non-Hodgkin
15
Neoplasms
14
Lymphoma, Mantle-Cell
14
Immunoglobulin Light-chain Amyloidosis
14
Nausea
13
Lymphoma, Large B-Cell, Diffuse
13
Vomiting
12
Breast Neoplasms
12
Hodgkin Disease
11
Waldenstrom Macroglobulinemia
10
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
9
Lymphoma, Follicular
9
Amyloidosis
9
Lymphoma, B-Cell, Marginal Zone
8
Leukemia, Myeloid, Acute
8
Smoldering Multiple Myeloma
7
Neoplasm Metastasis
7
Leukemia, Biphenotypic, Acute
6
Hematologic Neoplasms
6
Blast Crisis
6
Prostatic Neoplasms
5
Lymphoma, T-Cell, Cutaneous
5
Lymphoma, B-Cell
5
Interventions
Oxaliplatin
3
Capecitabine
3
Irinotecan
2
Gemcitabine
2
Cyclophosphamide
2
Colonoscopy
2
Bupivacaine
2
Aspirin
2
Ascorbic Acid
2
130-nm albumin-bound paclitaxel
2
trifluridine tipiracil drug combination
1
trametinib
1
penpulimab
1
pembrolizumab
1
lutetium Lu 177 dotatate
1
hetrombopag
1
halofantrine
1
guadecitabine
1
gadolinium ethoxybenzyl DTPA
1
gadobutrol
1
enoxaparin sodium
1
copper dotatate CU-64
1
camrelizumab
1
aumolertinib
1
XELOX
1
Ursodeoxycholic Acid
1
Urine Specimen Collection
1
Tomography, X-Ray Computed
1
Surveys and Questionnaires
1
Surgical Procedures, Operative
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Digestive System Diseases
×
Calcium Dobesilate
×
Clear all
NCT03723447
2021-02-17
TINGLE
Cedars-Sinai Medical Center
Phase 4
Completed
102 enrolled
9 charts